Showing results (141-150 of 244) with videos related to
Sort By:
Pageof 25
Research Communications in Chemical Pathology and Pharmacology|March 1, 1979
Studies on osteoporosis. II. Effect of estrogens and fluoride on experimental osteoporosis. A preliminary reportJ C Robin, B Schepart, H Calkins, et al.The Journal of Allergy and Clinical Immunology|June 11, 1991
Abnormal response to a human B cell growth factor in patients with common variable immunodeficiency (CVI)J L Ambrus, S Haneiwich, L Chesky, et al.Journal of Medicine|August 18, 2001
Study of antiangiogenic agents with possible therapeutic applications in neoplastic disorders and macular degenerationJ L Ambrus, C A Toumbis, C P Karakousis, et al.The Journal of Allergy and Clinical Immunology|June 1, 1987
Elevation of serum IgG levels and normalization of T4/T8 ratio after hepatitis in a patient with common variable hypogammaglobulinemiaS L Osur, M A Lillie, P B Chen, et al.Research Communications in Chemical Pathology and Pharmacology|February 1, 1984
Prostaglandin E2 production by human tumors. Defense mechanism against the host? A preliminary reportA Attallah, J B Lee, J L Ambrus, et al.Journal of Medicine|January 1, 1975
Laboratory and clinical evaluation of the radiation-potentiating activity of ethyl-N-bis (2,2-dimethylethylamidinophosphoro) carbamate (AB-132)W Regelson, J Hananian, M Bozzini, et al.The American Journal of Cardiology|April 21, 1982
Renal prostaglandin E2 biosynthesis: dependence on angiotensin IIA A Attallah, R A Stahl, D L Bloch, et al.Journal of Medicine|January 1, 1987
Mechanism of the potentiation of thrombolysis by pentoxifylline (Trental)J L Ambrus, C M Ambrus, M Mahfzah, et al.Journal of Medicine|January 1, 1982
The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitorK D Tourbaf, B E Dunlap, J L Ambrus, et al.Pathologie-Biologie|January 1, 1984
Antineoplastic effect of the pyrimido-pyrimidine derivative: RA 233W Biddle, R A Montagna, S S Leong, et al.Pageof 25